{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:02:16Z","timestamp":1795096936061,"version":"4.10.3"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Polyamines, namely putrescine, spermidine and spermine, are involved in multiple molecular pathways through their ability to bind nucleic acids and modulate protein stability. Their intracellular level is regulated through biosynthesis, catabolism and uptake from the extracellular milieu and the disruption of their homeostasis contributes to a variety of human disorders including cancer, as mainly described in solid tumors. Recently, there is an increasing interest in understanding polyamine functions in acute leukemias, due to the linkage between leukemic gene drivers, polyamine metabolism alterations and epigenetic defects. In particular, polyamine involvement in the regulation of acetylation and methylation is clinically relevant since epigenetic drugs are currently the backbone of novel therapeutic combinations, especially in acute myeloid leukemia (AML). With the exception of <jats:italic>methylthioadenosine phosphorylase<\/jats:italic> (<jats:italic>MTAP<\/jats:italic>), the enzyme leading to methionine regeneration that is frequently deleted in acute lymphoblastic leukemia (ALL), genes involved in polyamine metabolism and the interconnected methionine and arginine pathways are rarely targets of genetic lesions in acute leukemias. Conversely, functional alterations, including elevated polyamine levels and deregulated activity of enzymes involved in their metabolism, have been recently reported in leukemic cells. Notably, the polyamine catabolic enzyme spermidine\/spermine N1 acetyltransferase (SAT1) that is overexpressed in AML and associated with a myeloproliferative phenotype, is a tumor suppressor gene in ALL, suggesting diverse mechanisms of action across hematological malignancies according to the lineage commitment and the differentiation stage. In light of the promising results achieved in AML and ALL by selective targeting of protein arginine methyltransferase 5 (PRMT5) and methionine adenosyltransferase 2A (MAT2A), two enzymes at the crossroad between polyamine metabolism and protein methylation, in this review we examine and discuss the role of polyamines in epigenetic regulation and other biological processes supporting leukemic cell survival, proliferation and differentiation, which provides the opportunity to discover additional polyamine-related targets and design novel therapeutic combinations.<\/jats:p>","DOI":"10.1038\/s41420-025-02573-y","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:41:33Z","timestamp":1751481693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Polyamines at the crossroad between cell metabolism and epigenetic regulation in acute leukemias"],"prefix":"10.1038","volume":"11","author":[{"given":"Francesca","family":"Pirini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5774-7362","authenticated-orcid":false,"given":"Mouna","family":"Jandoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Azzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Mondrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2573_CR1","doi-asserted-by":"publisher","first-page":"C341","DOI":"10.1152\/ajpcell.00074.2024","volume":"327","author":"RS Schibalski","year":"2024","unstructured":"Schibalski RS, Shulha AS, Tsao BP, Palygin O, Ilatovskaya DV. The role of polyamine metabolism in cellular function and physiology. Am J Physiol Cell Physiol. 2024;327:C341\u201356. https:\/\/doi.org\/10.1152\/ajpcell.00074.2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"2573_CR2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1073\/pnas.60.4.1420","volume":"60","author":"D Russell","year":"1968","unstructured":"Russell D, Snyder SH. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci USA. 1968;60:1420\u20137. https:\/\/doi.org\/10.1073\/pnas.60.4.1420","journal-title":"Proc Natl Acad Sci USA"},{"key":"2573_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0014-5793(76)80540-6","volume":"67","author":"A Raina","year":"1976","unstructured":"Raina A, Pajula R-L, Eloranta T. A rapid assay method for spermidine and spermine synthases. Distribution of polyamine-synthesizing enzymes and methionine adenosyltransferase in rat tissues. FEBS Lett. 1976;67:252\u20135. https:\/\/doi.org\/10.1016\/0014-5793(76)80540-6","journal-title":"FEBS Lett"},{"key":"2573_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/bj3320651","volume":"332","author":"K Nishimura","year":"1998","unstructured":"Nishimura K, LIISANANTTI M, Muta Y, Kashiwagi K, Shirahata A, J\u00e4nne M, et al. Structure and activity of mouse S-adenosylmethionine decarboxylase gene promoters and properties of the encoded proteins. Biochem J. 1998;332:651\u20139. https:\/\/doi.org\/10.1042\/bj3320651","journal-title":"Biochem J"},{"key":"2573_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1357-2725(99)00140-5","volume":"32","author":"L Torres","year":"2000","unstructured":"Torres L, L\u00f3pez-Rodas G, Latasa MU, Carretero MV, Boukaba A, Rodr\u0131\u0301guez JL, et al. DNA methylation and histone acetylation of rat methionine adenosyltransferase 1A and 2A genes is tissue-specific. Int J Biochem Cell Biol. 2000;32:397\u2013404. https:\/\/doi.org\/10.1016\/S1357-2725(99)00140-5","journal-title":"Int J Biochem Cell Biol"},{"key":"2573_CR6","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1073\/pnas.93.12.6203","volume":"93","author":"T Nobori","year":"1996","unstructured":"Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL, et al. Genomic cloning of methylthioadenosine phosphorylase: A purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci USA. 1996;93:6203\u20138. https:\/\/doi.org\/10.1073\/pnas.93.12.6203","journal-title":"Proc Natl Acad Sci USA"},{"key":"2573_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0020-711X(81)90080-X","volume":"13","author":"FN Bolkenius","year":"1981","unstructured":"Bolkenius FN, Seiler N. Acetylderivatives as intermediates in polyamine catabolism. Int J Biochem. 1981;13:287\u201392. https:\/\/doi.org\/10.1016\/0020-711X(81)90080-X","journal-title":"Int J Biochem"},{"key":"2573_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.exphem.2014.02.008","volume":"42","author":"S Pirnes-Karhu","year":"2014","unstructured":"Pirnes-Karhu S, Jantunen E, M\u00e4ntymaa P, Mustjoki S, Alhonen L, Uimari A. Spermidine\/spermine N1-acetyltransferase activity associates with white blood cell count in myeloid leukemias. Exp Hematol. 2014;42:574\u201380. https:\/\/doi.org\/10.1016\/j.exphem.2014.02.008","journal-title":"Exp Hematol"},{"key":"2573_CR9","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1038\/s41375-021-01318-x","volume":"35","author":"G Simonetti","year":"2021","unstructured":"Simonetti G, Mengucci C, Padella A, Fonzi E, Picone G, Delpino C, et al. Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin\/DNA damage mutations. Leukemia. 2021;35:2813\u201326. https:\/\/doi.org\/10.1038\/s41375-021-01318-x","journal-title":"Leukemia"},{"key":"2573_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cncr.31837","volume":"125","author":"G Simonetti","year":"2019","unstructured":"Simonetti G, Padella A, do Valle IF, Fontana MC, Fonzi E, Bruno S, et al. Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery. Cancer. 2019;125:712\u201325. https:\/\/doi.org\/10.1002\/cncr.31837","journal-title":"Cancer"},{"key":"2573_CR11","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3390\/ijms23052755","volume":"23","author":"M Lejman","year":"2022","unstructured":"Lejman M, Cha\u0142upnik A, Chilimoniuk Z, Dobosz M. Genetic biomarkers and their clinical implications in B-cell acute lymphoblastic leukemia in children. Int J Mol Sci 2022;23:2755. https:\/\/doi.org\/10.3390\/ijms23052755","journal-title":"Int J Mol Sci"},{"key":"2573_CR12","doi-asserted-by":"publisher","unstructured":"Molina O, Bataller A, Thampi N, Ribera J, Granada I, Velasco P, et al. Near-haploidy and low-hypodiploidy in b-cell acute lymphoblastic leukemia: When less is too much. Cancers. 2021;14. https:\/\/doi.org\/10.3390\/cancers14010032","DOI":"10.3390\/cancers14010032"},{"key":"2573_CR13","first-page":"881","volume":"91","author":"D Mirebeau","year":"2006","unstructured":"Mirebeau D, Acquaviva C, Suciu S, Bertin R, Dastugue N, Robert A, et al. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica. 2006;91:881\u20135.","journal-title":"Haematologica"},{"key":"2573_CR14","doi-asserted-by":"publisher","unstructured":"Thakral D, Kaur G, Gupta R, Benard-Slagter A, Savola S, Kumar I, et al. Rapid identification of key copy number alterations in B- and T-cell acute lymphoblastic leukemia by digital multiplex ligation-dependent probe amplification. Front Oncol. 2019;9. https:\/\/doi.org\/10.3389\/fonc.2019.00871","DOI":"10.3389\/fonc.2019.00871"},{"key":"2573_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hon.3030","volume":"40","author":"S Kumari","year":"2022","unstructured":"Kumari S, Ali MS, Singh J, Arora M, Verma D, Pandey AK, et al. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia. Hematol Oncol. 2022;40:577\u201387. https:\/\/doi.org\/10.1002\/hon.3030","journal-title":"Hematol Oncol"},{"key":"2573_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/gcc.10188","volume":"37","author":"R Bertin","year":"2003","unstructured":"Bertin R, Acquaviva C, Mirebeau D, Guidal\u2010Giroux C, Vilmer E, Cav\u00e9 H. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia. Genes Chromosom Cancer. 2003;37:44\u201357. https:\/\/doi.org\/10.1002\/gcc.10188","journal-title":"Genes Chromosom Cancer"},{"key":"2573_CR17","doi-asserted-by":"publisher","first-page":"104535.","DOI":"10.1016\/j.esmoop.2025.104535","volume":"10","author":"H Ikushima","year":"2025","unstructured":"Ikushima H, Watanabe K, Shinozaki-Ushiku A, Oda K, Kage H. Pan-cancer clinical and molecular landscape of MTAP deletion in nationwide and international comprehensive genomic data. ESMO Open. 2025;10:104535. https:\/\/doi.org\/10.1016\/j.esmoop.2025.104535","journal-title":"ESMO Open"},{"key":"2573_CR18","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-11-1227","volume":"17","author":"I Iacobucci","year":"2011","unstructured":"Iacobucci I, Ferrari A, Lonetti A, Papayannidis C, Paoloni F, Trino S, et al. CDKN2A\/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. Clin Cancer Res. 2011;17:7413\u201323. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1227","journal-title":"Clin Cancer Res"},{"key":"2573_CR19","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3390\/diagnostics13091589","volume":"13","author":"M Ampatzidou","year":"2023","unstructured":"Ampatzidou M, Papadhimitriou SI, Paisiou A, Paterakis G, Tzanoudaki M, Papadakis V, et al. The prognostic effect of CDKN2A\/2B gene deletions in pediatric acute lymphoblastic leukemia (ALL): independent prognostic significance in BFM-based protocols. Diagnostics. 2023;13:1589. https:\/\/doi.org\/10.3390\/diagnostics13091589","journal-title":"Diagnostics"},{"key":"2573_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood.v71.6.1568.bloodjournal7161568","volume":"71","author":"S Traweek","year":"1988","unstructured":"Traweek S, Riscoe M, Ferro A, Braziel R, Magenis R, Fitchen J. Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features. Blood. 1988;71:1568\u201373. https:\/\/doi.org\/10.1182\/blood.v71.6.1568.bloodjournal7161568","journal-title":"Blood"},{"key":"2573_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00726-013-1546-5","volume":"46","author":"S Pirnes-Karhu","year":"2014","unstructured":"Pirnes-Karhu S, M\u00e4ntymaa P, Sironen R, M\u00e4kinen PI, Wojciechowski S, Juutinen S, et al. Enhanced polyamine catabolism disturbs hematopoietic lineage commitment and leads to a myeloproliferative disease in mice overexpressing spermidine\/spermine N1-acetyltransferase. Amino Acids. 2014;46:689\u2013700. https:\/\/doi.org\/10.1007\/s00726-013-1546-5","journal-title":"Amino Acids"},{"key":"2573_CR22","doi-asserted-by":"publisher","first-page":"18746","DOI":"10.1074\/jbc.272.30.18746","volume":"272","author":"M Pietil\u00e4","year":"1997","unstructured":"Pietil\u00e4 M, Alhonen L, Halmekyt\u00f6 M, Kanter P, J\u00e4nne J, Porter CW. Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in transgenic mice overexpressing spermidine\/spermine N1-acetyltransferase. J Biol Chem. 1997;272:18746\u201351. https:\/\/doi.org\/10.1074\/jbc.272.30.18746","journal-title":"J Biol Chem"},{"key":"2573_CR23","doi-asserted-by":"publisher","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA. 2016. https:\/\/doi.org\/10.1073\/pnas.1607152113","DOI":"10.1073\/pnas.1607152113"},{"key":"2573_CR24","doi-asserted-by":"publisher","first-page":"40076","DOI":"10.1074\/jbc.M406002200","volume":"279","author":"K Kee","year":"2004","unstructured":"Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, et al. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice. J Biol Chem. 2004;279:40076\u201383. https:\/\/doi.org\/10.1074\/jbc.M406002200","journal-title":"J Biol Chem"},{"key":"2573_CR25","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1158\/0008-5472.CAN-05-0229","volume":"65","author":"JM Tucker","year":"2005","unstructured":"Tucker JM, Murphy JT, Kisiel N, Diegelman P, Barbour KW, Davis C, et al. Potent modulation of intestinal tumorigenesis in Apcmin\/+ mice by the polyamine catabolic enzyme spermidine\/spermine N1- acetyltransferase. Cancer Res. 2005;65:5390\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0229","journal-title":"Cancer Res"},{"key":"2573_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.leukres.2009.12.021","volume":"34","author":"JP Annereau","year":"2010","unstructured":"Annereau JP, Brel V, Dumontet C, Guminski Y, Imbert T, Broussas M, et al. A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment. Leuk Res. 2010;34:1383\u20139. https:\/\/doi.org\/10.1016\/j.leukres.2009.12.021","journal-title":"Leuk Res"},{"key":"2573_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0145-2126(94)90070-1","volume":"18","author":"JD Walters","year":"1994","unstructured":"Walters JD, Wojcik MS. Polyamine transport in human promyelocytic leukemia cells and polymorphonuclear leukocytes. Leuk Res. 1994;18:703\u20138. https:\/\/doi.org\/10.1016\/0145-2126(94)90070-1","journal-title":"Leuk Res"},{"key":"2573_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1042\/bj3120933","volume":"312","author":"S Cl\u00e9ment","year":"1995","unstructured":"Cl\u00e9ment S, Delcros JG, Feuerstein BG. Spermine uptake is necessary to induce haemoglobin synthesis in murine erythroleukaemia cells. Biochem J. 1995;312:933\u20138. https:\/\/doi.org\/10.1042\/bj3120933","journal-title":"Biochem J"},{"key":"2573_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41420-018-0117-7","volume":"4","author":"K Tamari","year":"2018","unstructured":"Tamari K, Konno M, Asai A, Koseki J, Hayashi K, Kawamoto K, et al. Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells. Cell Death Discov. 2018;4:104. https:\/\/doi.org\/10.1038\/s41420-018-0117-7","journal-title":"Cell Death Discov"},{"key":"2573_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctrv.2011.04.013","volume":"37","author":"T Schoofs","year":"2011","unstructured":"Schoofs T, M\u00fcller-Tidow C. DNA methylation as a pathogenic event and as a therapeutic target in AML. Cancer Treat Rev 2011;37:13\u2013S18. https:\/\/doi.org\/10.1016\/j.ctrv.2011.04.013","journal-title":"Cancer Treat Rev"},{"key":"2573_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/nejmoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020;383:617\u201329. https:\/\/doi.org\/10.1056\/nejmoa2012971","journal-title":"N Engl J Med"},{"key":"2573_CR32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","volume":"27","author":"CL Jones","year":"2020","unstructured":"Jones CL, Stevens BM, Pollyea DA, Culp-Hill R, Reisz JA, Nemkov T, et al. Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells. Cell Stem Cell. 2020;27:748\u201364.e4. https:\/\/doi.org\/10.1016\/j.stem.2020.07.021","journal-title":"Cell Stem Cell"},{"key":"2573_CR33","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1182\/blood.v95.6.1942","volume":"95","author":"IH Wong","year":"2000","unstructured":"Wong IH, Ng MH, Huang DP, Lee JC. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood. 2000;95:1942\u20139. https:\/\/doi.org\/10.1182\/blood.v95.6.1942","journal-title":"Blood"},{"key":"2573_CR34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/leu.2008.130","volume":"22","author":"SQ Kuang","year":"2008","unstructured":"Kuang SQ, Tong WG, Yang H, Lin W, Lee MK, Fang ZH, et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia. 2008;22:1529\u201338. https:\/\/doi.org\/10.1038\/leu.2008.130","journal-title":"Leukemia"},{"key":"2573_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/leu.2010.282","volume":"25","author":"DJPM Stumpel","year":"2011","unstructured":"Stumpel DJPM, Schotte D, Lange-Turenhout EAM, Schneider P, Seslija L, De Menezes RX, et al. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: Major matters at a micro scale. Leukemia. 2011;25:429\u201339. https:\/\/doi.org\/10.1038\/leu.2010.282","journal-title":"Leukemia"},{"key":"2573_CR36","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2009-09-243634","volume":"115","author":"E Schafer","year":"2010","unstructured":"Schafer E, Irizarry R, Negi S, McIntyre E, Small D, Figueroa ME, et al. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: Biology and therapeutic targeting. Blood. 2010;115:4798\u2013809. https:\/\/doi.org\/10.1182\/blood-2009-09-243634","journal-title":"Blood"},{"key":"2573_CR37","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1182\/blood-2009-06-227660","volume":"114","author":"DJPM Stumpel","year":"2009","unstructured":"Stumpel DJPM, Schneider P, Van Roon EHJ, Boer JM, De Lorenzo P, Valsecchi MG, et al. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood. 2009;114:5490\u20138. https:\/\/doi.org\/10.1182\/blood-2009-06-227660","journal-title":"Blood"},{"key":"2573_CR38","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1172\/JCI66203","volume":"123","author":"ME Figueroa","year":"2013","unstructured":"Figueroa ME, Chen SC, Andersson AK, Phillips LA, Li Y, Sotzen J, et al. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest. 2013;123:3099\u2013111. https:\/\/doi.org\/10.1172\/JCI66203","journal-title":"J Clin Invest"},{"key":"2573_CR39","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2009-04-214668","volume":"115","author":"L Milani","year":"2010","unstructured":"Milani L, Lundmark A, Kiialainen A, Nordlund J, Flaegstad T, Forestier E, et al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood. 2010;115:1214\u201325. https:\/\/doi.org\/10.1182\/blood-2009-04-214668","journal-title":"Blood"},{"key":"2573_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-014-0039-z","volume":"7","author":"J Nordlund","year":"2015","unstructured":"Nordlund J, B\u00e4cklin CL, Zachariadis V, Cavelier L, Dahlberg J, \u00d6fverholm I, et al. Dna methylation-based subtype prediction for pediatric acute lymphoblastic leukemia. Clin Epigenetics. 2015;7:11. https:\/\/doi.org\/10.1186\/s13148-014-0039-z","journal-title":"Clin Epigenetics"},{"key":"2573_CR41","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","volume":"118","author":"LE Hogan","year":"2011","unstructured":"Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011;118:5218\u201326. https:\/\/doi.org\/10.1182\/blood-2011-04-345595","journal-title":"Blood"},{"key":"2573_CR42","doi-asserted-by":"publisher","unstructured":"Razvi SS, Choudhry H, Hasan MN, Hassan MA, Moselhy SS, Abualnaja KO, et al. Identification of deregulated signaling pathways in Jurkat cells in response to a novel acylspermidine analogue-N 4-erucoyl spermidine. Epigenetics Insights. 2018;11. https:\/\/doi.org\/10.1177\/2516865718814543","DOI":"10.1177\/2516865718814543"},{"key":"2573_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ajh.23778","volume":"89","author":"MJ Burke","year":"2014","unstructured":"Burke MJ, Lamba JK, Pounds S, Cao X, Ghodke\u2010Puranik Y, Lindgren BR, et al. A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed\/refractory acute lymphoblastic leukemia. Am J Hematol. 2014;89:889\u201395. https:\/\/doi.org\/10.1002\/ajh.23778","journal-title":"Am J Hematol"},{"key":"2573_CR44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bjh.13050","volume":"167","author":"CB Benton","year":"2014","unstructured":"Benton CB, Thomas DA, Yang H, Ravandi F, Rytting M, O'Brien S, et al. Safety and clinical activity of 5-aza-2\u2019-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed\/refractory acute lymphocytic leukaemia. Br J Haematol. 2014;167:356\u201365. https:\/\/doi.org\/10.1111\/bjh.13050","journal-title":"Br J Haematol"},{"key":"2573_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6092646","volume":"2018","author":"LT Rahmat","year":"2018","unstructured":"Rahmat LT, Damon LE. Venetoclax in combination with decitabine for relapsed T-cell acute lymphoblastic leukemia after allogeneic hematopoietic cell transplant. Case Rep Hematol. 2018;2018:1\u20133. https:\/\/doi.org\/10.1155\/2018\/6092646","journal-title":"Case Rep Hematol"},{"key":"2573_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.hemonc.2019.10.002","volume":"14","author":"N Farhadfar","year":"2021","unstructured":"Farhadfar N, Li Y, May WS, Adams CB. Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: a case report and review of literature. Hematol Oncol Stem Cell Ther. 2021;14:246\u201351","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2573_CR47","doi-asserted-by":"publisher","first-page":"e991","DOI":"10.1097\/MPH.0000000000002050","volume":"43","author":"MU Baig","year":"2021","unstructured":"Baig MU, Rytting M, Roth M, Morani AC, Nunez C, Lin P, et al. Venetoclax and decitabine in pediatric refractory T-cell lymphoblastic lymphoma. J Pediatr Hematol Oncol. 2021;43:e991\u201396. https:\/\/doi.org\/10.1097\/MPH.0000000000002050","journal-title":"J Pediatr Hematol Oncol"},{"key":"2573_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13045-018-0607-3","volume":"11","author":"C Roolf","year":"2018","unstructured":"Roolf C, Richter A, Konkolefski C, Knuebel G, Sekora A, Krohn S, et al. Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements. J Hematol Oncol. 2018;11:62. https:\/\/doi.org\/10.1186\/s13045-018-0607-3","journal-title":"J Hematol Oncol"},{"key":"2573_CR49","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/mc.20350","volume":"46","author":"G Wei","year":"2007","unstructured":"Wei G, Hobbs CA, DeFeo K, Hayes CS, Gilmour SK. Polyamine-mediated regulation of protein acetylation in murine skin and tumors. Mol Carcinogenesis. 2007;46:611\u20137. https:\/\/doi.org\/10.1002\/mc.20350","journal-title":"Mol Carcinogenesis"},{"key":"2573_CR50","first-page":"67","volume":"62","author":"CA Hobbs","year":"2002","unstructured":"Hobbs CA, Paul BA, Gilmour SK. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors. Cancer Res. 2002;62:67\u201374","journal-title":"Cancer Res"},{"key":"2573_CR51","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1074\/jbc.ra120.013833","volume":"295","author":"A Sakamoto","year":"2020","unstructured":"Sakamoto A, Terui Y, Uemura T, Igarashi K, Kashiwagi K. Polyamines regulate gene expression by stimulating translation of histone acetyltransferase mRNAs. J Biol Chem. 2020;295:8736\u201345. https:\/\/doi.org\/10.1074\/jbc.ra120.013833","journal-title":"J Biol Chem"},{"key":"2573_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, Phillips LA, et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature. 2011;471:235\u20139. https:\/\/doi.org\/10.1038\/nature09727","journal-title":"Nature"},{"key":"2573_CR53","doi-asserted-by":"publisher","first-page":"64071","DOI":"10.18632\/oncotarget.11773","volume":"7","author":"CM Lindqvist","year":"2016","unstructured":"Lindqvist CM, Lundmark A, Nordlund J, Freyhult E, Ekman D, Alml\u00f6f JC, et al. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. Oncotarget. 2016;7:64071\u201388. https:\/\/doi.org\/10.18632\/oncotarget.11773","journal-title":"Oncotarget"},{"key":"2573_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157\u201363. https:\/\/doi.org\/10.1038\/nature10725","journal-title":"Nature"},{"key":"2573_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2016.10.008","volume":"30","author":"S Lin","year":"2016","unstructured":"Lin S, Luo RT, Ptasinska A, Kerry J, Assi SA, Wunderlich M, et al. Instructive role of MLL-fusion proteins revealed by a model of t(4;11) Pro-B acute lymphoblastic leukemia. Cancer Cell. 2016;30:737\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.008","journal-title":"Cancer Cell"},{"key":"2573_CR56","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2008.002436","volume":"94","author":"RK Slany","year":"2009","unstructured":"Slany RK. The molecular biology of mixed lineage leukemia. Haematologica. 2009;94:984\u201393. https:\/\/doi.org\/10.3324\/haematol.2008.002436","journal-title":"Haematologica"},{"key":"2573_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gr.209163.116","volume":"27","author":"M Qian","year":"2017","unstructured":"Qian M, Zhang H, Kham SKY, Liu S, Jiang C, Zhao X, et al. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Res. 2017;27:185\u201395. https:\/\/doi.org\/10.1101\/gr.209163.116","journal-title":"Genome Res"},{"key":"2573_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/onc.2015.92","volume":"35","author":"G Giotopoulos","year":"2016","unstructured":"Giotopoulos G, Chan WI, Horton SJ, Ruau D, Gallipoli P, Fowler A, et al. The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia. Oncogene. 2016;35:279\u201389. https:\/\/doi.org\/10.1038\/onc.2015.92","journal-title":"Oncogene"},{"key":"2573_CR59","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/bloodadvances.2022008787","volume":"7","author":"F Pan","year":"2023","unstructured":"Pan F, Iwasaki M, Wu W, Jiang Y, Yang X, Zhu L, et al. Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells. Blood Adv. 2023;7:2504\u201319. https:\/\/doi.org\/10.1182\/bloodadvances.2022008787","journal-title":"Blood Adv"},{"key":"2573_CR60","doi-asserted-by":"publisher","unstructured":"Wang L, Gural A, Sun XJ, Zhao X, Perna F, Huang G, et al. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science (80-). 2011. https:\/\/doi.org\/10.1126\/science.1201662","DOI":"10.1126\/science.1201662"},{"key":"2573_CR61","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","volume":"41","author":"L Nicosia","year":"2023","unstructured":"Nicosia L, Spencer GJ, Brooks N, Amaral FMR, Basma NJ, Chadwick JA, et al. Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies. Cancer Cell. 2023;41:2136\u201353.e13. https:\/\/doi.org\/10.1016\/j.ccell.2023.11.001","journal-title":"Cancer Cell"},{"key":"2573_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0393-8","volume":"17","author":"Q Lai","year":"2019","unstructured":"Lai Q, He Y, Peng X, Zhou X, Liang D, Wang L. Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia. Cell Commun Signal. 2019;17:86. https:\/\/doi.org\/10.1186\/s12964-019-0393-8","journal-title":"Cell Commun Signal"},{"key":"2573_CR63","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1158\/1541-7786.MCR-18-0922","volume":"17","author":"LE Richter","year":"2019","unstructured":"Richter LE, Wang Y, Becker ME, Coburn RA, Williams JT, Amador C, et al. HDAC1 is a required cofactor of CBFb-SMMHC and a potential therapeutic target in inversion 16 acute myeloid leukemia. Mol Cancer Res. 2019;17:1241\u201352. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0922","journal-title":"Mol Cancer Res"},{"key":"2573_CR64","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1093\/nar\/gkac613","volume":"50","author":"S Gregoricchio","year":"2022","unstructured":"Gregoricchio S, Polit L, Esposito M, Berthelet J, Delestr\u00e9 L, Evanno E, et al. HDAC1 and PRC2 mediate combinatorial control in SPI1\/PU.1-dependent gene repression in murine erythroleukaemia. Nucleic Acids Res. 2022;50:7938\u201358. https:\/\/doi.org\/10.1093\/nar\/gkac613","journal-title":"Nucleic Acids Res"},{"key":"2573_CR65","doi-asserted-by":"publisher","unstructured":"Moreno DA, Scrideli CA, Cortez MAA, De Paula Queiroz R, Valera ET, Da Silva Silveira V, et al. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia: Research paper. Br J Haematol. 2010;150:665\u201373. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08301.x","DOI":"10.1111\/j.1365-2141.2010.08301.x"},{"key":"2573_CR66","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.leukres.2013.07.016","volume":"37","author":"B Gruhn","year":"2013","unstructured":"Gruhn B, Naumann T, Gruner D, Walther M, Wittig S, Becker S, et al. The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia. Leuk Res. 2013;37:1200\u20137. https:\/\/doi.org\/10.1016\/j.leukres.2013.07.016","journal-title":"Leuk Res"},{"key":"2573_CR67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1101\/gad.552310","volume":"24","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 2010;24:455\u201369. https:\/\/doi.org\/10.1101\/gad.552310","journal-title":"Genes Dev"},{"key":"2573_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1127-7","volume":"19","author":"P Wang","year":"2020","unstructured":"Wang P, Wang Z, Liu J. Role of HDACs in normal and malignant hematopoiesis. Mol Cancer. 2020;19:5. https:\/\/doi.org\/10.1186\/s12943-019-1127-7","journal-title":"Mol Cancer."},{"key":"2573_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0014-4827(03)00352-5","volume":"290","author":"CA Hobbs","year":"2003","unstructured":"Hobbs CA, Paul BA, Gilmour SK. Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation. Exp Cell Res. 2003;290:427\u201336. https:\/\/doi.org\/10.1016\/S0014-4827(03)00352-5","journal-title":"Exp Cell Res"},{"key":"2573_CR70","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1158\/2159-8290.CD-22-0366","volume":"13","author":"HJ Uckelmann","year":"2023","unstructured":"Uckelmann HJ, Haarer EL, Takeda R, Wong EM, Hatton C, Marinaccio C, et al. Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia. Cancer Discov. 2023;13:746\u201365. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0366","journal-title":"Cancer Discov"},{"key":"2573_CR71","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s13277-015-3912-2","volume":"37","author":"ED Gupta","year":"2016","unstructured":"Gupta ED, Pachauri M, Ghosh PC, Rajam MV. Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line. Tumor Biol. 2016;37:1159\u201371. https:\/\/doi.org\/10.1007\/s13277-015-3912-2","journal-title":"Tumor Biol"},{"key":"2573_CR72","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.leukres.2008.01.017","volume":"32","author":"PC Hsu","year":"2008","unstructured":"Hsu PC, Hung HC, Liao YF, Liu CC, Tsay GJ, Liu GY. Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells. Leuk Res. 2008;32:1530\u201340. https:\/\/doi.org\/10.1016\/j.leukres.2008.01.017","journal-title":"Leuk Res"},{"key":"2573_CR73","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0145-2126(99)00161-7","volume":"24","author":"SH Choi","year":"2000","unstructured":"Choi SH, Kim SW, Choi DH, Min BH, Chun BG. Polyamine-depletion induces p27(Kip1) and enhances dexamethasone-induced G1 arrest and apoptosis in human T lymphoblastic leukemia cells. Leuk Res. 2000;24:119\u201327. https:\/\/doi.org\/10.1016\/S0145-2126(99)00161-7","journal-title":"Leuk Res"},{"key":"2573_CR74","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcb.29192","volume":"121","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lei P, Qiao H, Sun K, Lu X, Bao F, et al. MicroRNA-33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A-2. J Cell Biochem. 2020;121:385\u201393. https:\/\/doi.org\/10.1002\/jcb.29192","journal-title":"J Cell Biochem"},{"key":"2573_CR75","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/CAD.0000000000000550","volume":"28","author":"Y Liu","year":"2017","unstructured":"Liu Y, Xue F, Zhang Y, Lei P, Wang Z, Zhu Z, et al. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation. Anticancer Drugs. 2017;28:1097\u2013105. https:\/\/doi.org\/10.1097\/CAD.0000000000000550","journal-title":"Anticancer Drugs"},{"key":"2573_CR76","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1182\/blood-2005-03-037648","volume":"109","author":"S Balabanov","year":"2007","unstructured":"Balabanov S, Gontarewicz A, Ziegler P, Hartmann U, Kammer W, Copland M, et al. Hypusination of eukaryotic initiation factor 5A(eIF5A): A novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood. 2007;109:1701\u201311. https:\/\/doi.org\/10.1182\/blood-2005-03-037648","journal-title":"Blood"},{"key":"2573_CR77","doi-asserted-by":"publisher","first-page":"177596.","DOI":"10.1016\/j.ejphar.2025.177596","volume":"997","author":"X Xiong","year":"2025","unstructured":"Xiong X, Du Y, Liu P, Li X, Lai X, Miao H, et al. Unveiling EIF5A2: a multifaceted player in cellular regulation, tumorigenesis and drug resistance. Eur J Pharmacol. 2025;997:177596. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177596","journal-title":"Eur J Pharmacol"},{"key":"2573_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01069-9","volume":"14","author":"C Gondran","year":"2024","unstructured":"Gondran C, Dumas P-Y, B\u00e9rard E, Bidet A, Delabesse E, Tavitian S, et al. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)\/BCR::ABL1. A DATAML registry study. Blood Cancer J. 2024;14:91. https:\/\/doi.org\/10.1038\/s41408-024-01069-9","journal-title":"Blood Cancer J"},{"key":"2573_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molcel.2019.08.005","volume":"76","author":"H Zhang","year":"2019","unstructured":"Zhang H, Alsaleh G, Feltham J, Sun Y, Napolitano G, Riffelmacher T, et al. Polyamines control eIF5A hypusination, TFEB translation, and autophagy to reverse B cell senescence. Mol Cell. 2019;76:110\u201325.e9. https:\/\/doi.org\/10.1016\/j.molcel.2019.08.005","journal-title":"Mol Cell"},{"key":"2573_CR80","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/2643-3230.BCD-20-0029","volume":"2","author":"S Yun","year":"2021","unstructured":"Yun S, Vincelette ND, Yu X, Watson GW, Fernandez MR, Yang C, et al. TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia. Blood Cancer Discov. 2021;2:162\u201385. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0029","journal-title":"Blood Cancer Discov"},{"key":"2573_CR81","doi-asserted-by":"publisher","unstructured":"Oehme I, Linke JP, B\u00f6ck BC, Milde T, Lodrini M, Hartenstein B, et al. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc Natl Acad Sci USA. 2013;110. https:\/\/doi.org\/10.1073\/pnas.1300113110","DOI":"10.1073\/pnas.1300113110"},{"key":"2573_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15368","volume":"8","author":"Y Hai","year":"2017","unstructured":"Hai Y, Shinsky SA, Porter NJ, Christianson DW. Histone deacetylase 10 structure and molecular function as a polyamine deacetylase. Nat Commun. 2017;8:15368. https:\/\/doi.org\/10.1038\/ncomms15368","journal-title":"Nat Commun"},{"key":"2573_CR83","doi-asserted-by":"publisher","first-page":"102407","DOI":"10.1016\/j.jbc.2022.102407","volume":"298","author":"TM Stewart","year":"2022","unstructured":"Stewart TM, Foley JR, Holbert CE, Klinke G, Poschet G, Steimbach RR, et al. Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth. J Biol Chem. 2022;298:102407. https:\/\/doi.org\/10.1016\/j.jbc.2022.102407","journal-title":"J Biol Chem"},{"key":"2573_CR84","doi-asserted-by":"publisher","unstructured":"Feng P, Zhang J, Zhang J, Liu X, Pan L, Chen D, et al. Deacetylation of YAP1 promotes the resistance to chemo- and targeted therapy in FLT3-ITD+ AML cells. Front Cell Dev Biol. 2022;10. https:\/\/doi.org\/10.3389\/fcell.2022.842214","DOI":"10.3389\/fcell.2022.842214"},{"key":"2573_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11010-005-5755-4","volume":"277","author":"R Paxton","year":"2005","unstructured":"Paxton R, Ye L. Regulation of heart insulin receptor tyrosine kinase activity by magnesium and spermine. Mol Cell Biochem. 2005;277:7\u201317. https:\/\/doi.org\/10.1007\/s11010-005-5755-4","journal-title":"Mol Cell Biochem"},{"key":"2573_CR86","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1158\/0008-5472.CAN-09-0511","volume":"69","author":"AE Wahner Hendrickson","year":"2009","unstructured":"Wahner Hendrickson AE, Haluska P, Schneider PA, Loegering DA, Peterson KL, Attar R, et al. Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: Effect of the dual-receptor inhibitor BMS-536924 in vitro. Cancer Res. 2009;69:7635\u201343. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0511","journal-title":"Cancer Res"},{"key":"2573_CR87","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","volume":"34","author":"H Ye","year":"2018","unstructured":"Ye H, Adane B, Khan N, Alexeev E, Nusbacher N, Minhajuddin M, et al. Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells. Cancer Cell. 2018;34:659\u201373.e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.08.016","journal-title":"Cancer Cell"},{"key":"2573_CR88","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4143\/crt.2002.34.3.198","volume":"34","author":"JY Lee","year":"2002","unstructured":"Lee JY, Lee KH, Kim BG. Polyamines regulate growth factor-induced protein phosphorylation in MCF-7 human breast cancer cells. Cancer Res Treat. 2002;34:198\u2013204. https:\/\/doi.org\/10.4143\/crt.2002.34.3.198","journal-title":"Cancer Res Treat"},{"key":"2573_CR89","doi-asserted-by":"publisher","first-page":"19055","DOI":"10.1074\/jbc.M600910200","volume":"281","author":"Y Huang","year":"2006","unstructured":"Huang Y, Keen JC, Pledgie A, Marton LJ, Zhu T, Sukumar S, et al. Polyamine analogues down-regulate estrogen receptor \u03b1 expression in human breast cancer cells. J Biol Chem. 2006;281:19055\u201363. https:\/\/doi.org\/10.1074\/jbc.M600910200","journal-title":"J Biol Chem"},{"key":"2573_CR90","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1016\/j.ajpath.2016.08.021","volume":"186","author":"A Shukla-Dave","year":"2016","unstructured":"Shukla-Dave A, Castillo-Martin M, Chen M, Lobo J, Gladoun N, Collazo-Lorduy A, et al. Ornithine decarboxylase is sufficient for prostate tumorigenesis via androgen receptor signaling. Am J Pathol. 2016;186:3131\u201345. https:\/\/doi.org\/10.1016\/j.ajpath.2016.08.021","journal-title":"Am J Pathol"},{"key":"2573_CR91","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0006-291X(03)00834-9","volume":"305","author":"MK Kwak","year":"2003","unstructured":"Kwak MK, Kensler TW, Casero RA. Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: Effect of the polyamine metabolite acrolein. Biochem Biophys Res Commun. 2003;305:662\u201370. https:\/\/doi.org\/10.1016\/S0006-291X(03)00834-9","journal-title":"Biochem Biophys Res Commun"},{"key":"2573_CR92","doi-asserted-by":"publisher","first-page":"110626","DOI":"10.1016\/j.cellsig.2023.110626","volume":"105","author":"X Chu","year":"2023","unstructured":"Chu X, Zhong L, Dan W, Wang X, Zhang Z, Liu Z, et al. DNMT3A R882H mutation promotes acute leukemic cell survival by regulating glycolysis through the NRF2\/NQO1 axis. Cell Signal. 2023;105:110626. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110626","journal-title":"Cell Signal"},{"key":"2573_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16213-9","volume":"11","author":"H Anteneh","year":"2020","unstructured":"Anteneh H, Fang J, Song J. Structural basis for impairment of DNA methylation by the DNMT3A R882H mutation. Nat Commun. 2020;11:2294. https:\/\/doi.org\/10.1038\/s41467-020-16213-9","journal-title":"Nat Commun"},{"key":"2573_CR94","doi-asserted-by":"publisher","first-page":"14040","DOI":"10.1002\/jcp.28091","volume":"234","author":"LXT Nguyen","year":"2019","unstructured":"Nguyen LXT, Troadec E, Kalvala A, Kumar B, Hoang DH, Viola D, et al. The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML. J Cell Physiol. 2019;234:14040\u20139. https:\/\/doi.org\/10.1002\/jcp.28091","journal-title":"J Cell Physiol"},{"key":"2573_CR95","doi-asserted-by":"publisher","first-page":"876556","DOI":"10.3389\/fonc.2022.876556","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Liu X, Kang Q, Pan C, Zhang T, Feng C, et al. Nrf2 overexpression decreases vincristine chemotherapy sensitivity through the PI3K-AKT pathway in adult B-cell acute lymphoblastic leukemia. Front Oncol. 2022;12:876556. https:\/\/doi.org\/10.3389\/fonc.2022.876556","journal-title":"Front Oncol"},{"key":"2573_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46776-w","volume":"15","author":"G Bi","year":"2024","unstructured":"Bi G, Liang J, Bian Y, Shan G, Huang Y, Lu T, et al. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nat Commun. 2024;15:2461. https:\/\/doi.org\/10.1038\/s41467-024-46776-w","journal-title":"Nat Commun"},{"key":"2573_CR97","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/sj.onc.1205400","volume":"21","author":"B Hoffman","year":"2002","unstructured":"Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene. 2002;21:3414\u201321. https:\/\/doi.org\/10.1038\/sj.onc.1205400","journal-title":"Oncogene"},{"key":"2573_CR98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cpt19656131","volume":"6","author":"RH Levin","year":"1965","unstructured":"Levin RH, Henderson E, Karon M, Freireich EJ. Treatment of acute leukemia with methylglyoxal-bis-guanylhydrazone (methyl GAG). Clin Pharmacol Ther. 1965;6:31\u201342","journal-title":"Clin Pharmacol Ther"},{"key":"2573_CR99","doi-asserted-by":"publisher","first-page":"103881","DOI":"10.1016\/j.isci.2022.103881","volume":"25","author":"Y Xu","year":"2022","unstructured":"Xu Y, Fang H, Chen Y, Tang Y, Sun H, Kong Z, et al. The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia. iScience. 2022;25:103881. https:\/\/doi.org\/10.1016\/j.isci.2022.103881","journal-title":"iScience"},{"key":"2573_CR100","doi-asserted-by":"publisher","unstructured":"Rondeau V, Berman JM, Ling T, O\u2019Brien C, Culp-Hill R, Reisz JA, et al. Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models. Sci Transl Med. 2024;16. https:\/\/doi.org\/10.1126\/scitranslmed.adn1285","DOI":"10.1126\/scitranslmed.adn1285"},{"key":"2573_CR101","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2014-09-600643","volume":"125","author":"F Mussai","year":"2015","unstructured":"Mussai F, Egan S, Higginbotham-Jones J, Perry T, Beggs A, Odintsova E, et al. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood. 2015;125:2386\u201396. https:\/\/doi.org\/10.1182\/blood-2014-09-600643","journal-title":"Blood"},{"key":"2573_CR102","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/ijc.31170","volume":"142","author":"C De Santo","year":"2018","unstructured":"De Santo C, Booth S, Vardon A, Cousins A, Tubb V, Perry T, et al. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100. Int J Cancer. 2018;142:1490\u2013502. https:\/\/doi.org\/10.1002\/ijc.31170","journal-title":"Int J Cancer"},{"key":"2573_CR103","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"CP Hernandez","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, et al. Pegylated arginase I: A potential therapeutic approach in T-ALL. Blood. 2010;115:5214\u201321. https:\/\/doi.org\/10.1182\/blood-2009-12-258822","journal-title":"Blood"},{"key":"2573_CR104","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/leu.2012.247","volume":"27","author":"K Morrow","year":"2013","unstructured":"Morrow K, Hernandez CP, Raber P, Del Valle L, Wilk AM, Majumdar S, et al. Anti-leukemic mechanisms of pegylated arginase i in acute lymphoblastic T-cell leukemia. Leukemia. 2013;27:569\u201377. https:\/\/doi.org\/10.1038\/leu.2012.247","journal-title":"Leukemia"},{"key":"2573_CR105","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1182\/blood-2014-10-608133","volume":"125","author":"F Miraki-Moud","year":"2015","unstructured":"Miraki-Moud F, Ghazaly E, Ariza-McNaughton L, Hodby KA, Clear A, Anjos-Afonso F, et al. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo. Blood. 2015;125:4060\u20138. https:\/\/doi.org\/10.1182\/blood-2014-10-608133","journal-title":"Blood"},{"key":"2573_CR106","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bjh.18560","volume":"200","author":"F Mussai","year":"2023","unstructured":"Mussai F, De Santo C, Cheng P, Thomas IF, Ariti C, Upton L, et al. A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia: Results from the LI-1 trial. Br J Haematol. 2023;200:573\u20138. https:\/\/doi.org\/10.1111\/bjh.18560","journal-title":"Br J Haematol"},{"key":"2573_CR107","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41375-024-02222-w","volume":"38","author":"J Guo","year":"2024","unstructured":"Guo J, Buettner R, Du L, Li Z, Liu W, Su R, et al. 8-Cl-Ado and 8-NH2-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia. Leukemia. 2024;38:1236\u201345. https:\/\/doi.org\/10.1038\/s41375-024-02222-w","journal-title":"Leukemia"},{"key":"2573_CR108","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis K, Koike-Yusa H, De Braekeleer E, Li Y, Metzakopian E, Dovey OM. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep.2016;17:1193\u2013205. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.079","journal-title":"Cell Rep."},{"key":"2573_CR109","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2018-99-115004","volume":"132","author":"AV Taylor","year":"2018","unstructured":"Taylor AV, Adao RR, Castro C, Domingues AF, Griffin JL, Curti A, et al. S-adenosyl methionine synthesis impacts maintenance of acute myeloid leukemia cells with regulation of transcriptional elongation. Blood. 2018;132:2605. https:\/\/doi.org\/10.1182\/blood-2018-99-115004","journal-title":"Blood"},{"key":"2573_CR110","doi-asserted-by":"publisher","first-page":"16295","DOI":"10.1002\/jcp.28294","volume":"234","author":"R Buettner","year":"2019","unstructured":"Buettner R, Nguyen LXT, Kumar B, Morales C, Liu C, Chen LS, et al. 8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia. J Cell Physiol. 2019;234:16295\u2013303. https:\/\/doi.org\/10.1002\/jcp.28294","journal-title":"J Cell Physiol"},{"key":"2573_CR111","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-021-01076-4","volume":"14","author":"R Buettner","year":"2021","unstructured":"Buettner R, Nguyen LXT, Morales C, Chen MH, Wu X, Chen LS, et al. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine. J Hematol Oncol. 2021;14:70. https:\/\/doi.org\/10.1186\/s13045-021-01076-4","journal-title":"J Hematol Oncol"},{"key":"2573_CR112","doi-asserted-by":"publisher","unstructured":"Mavrakis KJ, Robert McDonald E, Schlabach MR, Billy E, Hoffman GR, DeWeck A, et al. Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5. Science (80-). 2016. https:\/\/doi.org\/10.1126\/science.aad5944","DOI":"10.1126\/science.aad5944"},{"key":"2573_CR113","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1182\/blood.v88.8.3083.bloodjournal8883083","volume":"88","author":"A Batova","year":"1996","unstructured":"Batova A, Diccianni M, Nobori T, Vu T, Yu J, Bridgeman L, et al. Frequent deletion in the methylthioadenosine phosphorylase gene in T- cell acute lymphoblastic leukemia: Strategies for enzyme-targeted therapy. Blood. 1996;88:3083\u201390. https:\/\/doi.org\/10.1182\/blood.v88.8.3083.bloodjournal8883083","journal-title":"Blood"},{"key":"2573_CR114","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/leu.2015.308","volume":"30","author":"SS Tarighat","year":"2016","unstructured":"Tarighat SS, Santhanam R, Frankhouser D, Radomska HS, Lai H, Anghelina M, et al. The dual epigenetic role of PRMT5 in acute myeloid leukemia: Gene activation and repression via histone arginine methylation. Leukemia. 2016;30:789\u201399. https:\/\/doi.org\/10.1038\/leu.2015.308","journal-title":"Leukemia"},{"key":"2573_CR115","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.1126\/sciadv.abp9005","volume":"8","author":"P Zhang","year":"2022","unstructured":"Zhang P, Brinton LT, Gharghabi M, Sher S, Williams K, Cannon M, et al. Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor\u2013mediated synergistic antileukemic actions. Sci Adv. 2022;8:9005. https:\/\/doi.org\/10.1126\/sciadv.abp9005","journal-title":"Sci Adv"},{"key":"2573_CR116","doi-asserted-by":"publisher","first-page":"102282","DOI":"10.1016\/j.redox.2022.102282","volume":"51","author":"MM Szewczyk","year":"2022","unstructured":"Szewczyk MM, Luciani GM, Vu V, Murison A, Dilworth D, Barghout SH, et al. PRMT5 regulates ATF4 transcript splicing and oxidative stress response. Redox Biol. 2022;51:102282. https:\/\/doi.org\/10.1016\/j.redox.2022.102282","journal-title":"Redox Biol"},{"key":"2573_CR117","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.celrep.2018.08.002","volume":"24","author":"PJ Hamard","year":"2018","unstructured":"Hamard PJ, Santiago GE, Liu F, Karl DL, Martinez C, Man N, et al. PRMT5 regulates DNA repair by controlling the alternative splicing of histone-modifying enzymes. Cell Rep. 2018;24:2643\u201357. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.002","journal-title":"Cell Rep"},{"key":"2573_CR118","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","volume":"36","author":"JY Fong","year":"2019","unstructured":"Fong JY, Pignata L, Goy PA, Kawabata KC, Lee SCW, Koh CM, et al. Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation. Cancer Cell. 2019;36:194\u2013209.e9. https:\/\/doi.org\/10.1016\/j.ccell.2019.07.003","journal-title":"Cancer Cell"},{"key":"2573_CR119","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/leu.2017.206","volume":"32","author":"S Kaushik","year":"2018","unstructured":"Kaushik S, Liu F, Veazey KJ, Gao G, Das P, Neves LF, et al. Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML. Leukemia. 2018;32:499\u2013509. https:\/\/doi.org\/10.1038\/leu.2017.206","journal-title":"Leukemia"},{"key":"2573_CR120","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1158\/1078-0432.CCR-18-2342","volume":"25","author":"M Mei","year":"2019","unstructured":"Mei M, Zhang R, Zhou ZW, Ying Z, Wang J, Zhang H, et al. PRMT5-mediated H4R3sme2 confers cell differentiation in pediatric B-cell precursor acute lymphoblastic leukemia. Clin Cancer Res. 2019;25:2633\u201343. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2342","journal-title":"Clin Cancer Res"},{"key":"2573_CR121","doi-asserted-by":"publisher","unstructured":"Gamble LD, Purgato S, Murray J, Xiao L, Yu DMT, Hanssen KM, et al. Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma. Sci Transl Med. 2019;11. https:\/\/doi.org\/10.1126\/scitranslmed.aau1099","DOI":"10.1126\/scitranslmed.aau1099"},{"key":"2573_CR122","first-page":"684","volume":"8","author":"HA Hahm","year":"2002","unstructured":"Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, et al. Phase I study of N1, N11-diethylnorspermine in patients with non-small cell lung cancer. Clin Cancer Res. 2002;8:684\u201390","journal-title":"Clin Cancer Res"},{"key":"2573_CR123","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/0277-5379(87)90141-6","volume":"23","author":"Y Horn","year":"1987","unstructured":"Horn Y, Schechter PJ, Marton LJ. Phase I-II clinical trial with alpha-difluoromethylornithine-An inhibitor of polyamine biosynthesis. Eur J Cancer Clin Oncol. 1987;23:1103\u20137. https:\/\/doi.org\/10.1016\/0277-5379(87)90141-6","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2573_CR124","doi-asserted-by":"publisher","unstructured":"Streiff RR, Bender JF. Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies. Invest New Drugs. 2001;19:29\u201339. https:\/\/doi.org\/10.1023\/A:1006448516938","DOI":"10.1023\/A:1006448516938"},{"key":"2573_CR125","unstructured":"Wolff AC, Armstrong DK, Fetting JH, Carducci MK, Riley CD, Bender JF, et al. A phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin Cancer Res. 2003;9:5922\u20138"},{"key":"2573_CR126","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/ijc.35362","volume":"156","author":"W Gao","year":"2025","unstructured":"Gao W, Karsa M, Xiao L, Spurling D, Karsa A, Ronca E, et al. Polyamine depletion limits progression of acute leukaemia. Int J Cancer. 2025;156:2360\u201376. https:\/\/doi.org\/10.1002\/ijc.35362.","journal-title":"Int J Cancer"},{"key":"2573_CR127","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jcp.1041310320","volume":"131","author":"E Meilhoc","year":"1987","unstructured":"Meilhoc E, Moutin MJ, Osborne HB. Modulation of murine erythroleukemic cell differentiation by inhibitors of polyamine biosynthesis. J Cell Physiol. 1987;131:465\u201371. https:\/\/doi.org\/10.1002\/jcp.1041310320","journal-title":"J Cell Physiol"},{"key":"2573_CR128","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.6950518","volume":"216","author":"GD Luk","year":"1982","unstructured":"Luk GD, Civin CI, Weissman RM, Baylin SB. Ornithine decarboxylase: essential in proliferation but not differentiation of human promyelocytic leukemia cells. Science. 1982;216:75\u20137. https:\/\/doi.org\/10.1126\/science.6950518","journal-title":"Science"},{"key":"2573_CR129","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1182\/blood.v63.5.1153.bloodjournal6351153","volume":"63","author":"M Sugiura","year":"1984","unstructured":"Sugiura M, Shafman T, Mitchell T, Griffin J, Kufe D. Involvement of spermidine in proliferation and differentiation of human promyelocytic leukemia cells. Blood. 1984;63:1153\u20138. https:\/\/doi.org\/10.1182\/blood.v63.5.1153.bloodjournal6351153","journal-title":"Blood"},{"key":"2573_CR130","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1042\/bj3090787","volume":"309","author":"S Cl\u00e9ment","year":"1995","unstructured":"Cl\u00e9ment S, Delcros JG, Basu HS, Quash G, Marton LJ, Feuerstein BG. The structure of polyamine analogues determines haemoglobin production and cytotoxicity in murine erythroleukaemia cells. Biochem J. 1995;309:787\u201391. https:\/\/doi.org\/10.1042\/bj3090787","journal-title":"Biochem J"},{"key":"2573_CR131","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.biopha.2017.06.019","volume":"93","author":"SS Razvi","year":"2017","unstructured":"Razvi SS, Choudhry H, Moselhy SS, Kumosani TA, Hasan MN, Zamzami MA, et al. Synthesis, screening and pro-apoptotic activity of novel acyl spermidine derivatives on human cancer cell lines. Biomed Pharmacother. 2017;93:190\u2013201. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.019","journal-title":"Biomed Pharmacother"},{"key":"2573_CR132","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj\/neo\/7900208","volume":"4","author":"AL Miller","year":"2002","unstructured":"Miller AL, Johnson BH, Medh RD, Townsend CM, Thompson EB. Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells. Neoplasia. 2002;4:68\u201381. https:\/\/doi.org\/10.1038\/sj\/neo\/7900208","journal-title":"Neoplasia"},{"key":"2573_CR133","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biochi.2018.12.012","volume":"158","author":"NE Fedorova","year":"2019","unstructured":"Fedorova NE, Chernoryzh YY, Vinogradskaya GR, Emelianova SS, Zavalyshina LE, Yurlov KI, et al. Inhibitor of polyamine catabolism MDL72.527 restores the sensitivity to doxorubicin of monocytic leukemia Thp-1 cells infected with human cytomegalovirus. Biochimie. 2019;158:82\u201389. https:\/\/doi.org\/10.1016\/j.biochi.2018.12.012","journal-title":"Biochimie"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02573-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:41:34Z","timestamp":1751481694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02573-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":133,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02573-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"301"}}